Related Experiment Video
Updated: Jul 17, 2026
08:23
Optimization of Performance Parameters of the TAGGG Telomere Length Assay
Published on: April 21, 2023
Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas
Sarah H Walsh1, Pawel Grabowski, Mattias Berglund
1Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden.
European Journal of Haematology
|February 9, 2007
Summary
Telomere length varies across B-cell malignancies, correlating with specific subtypes like chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL) but not always with germinal center (GC) origin.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Telomere length has been linked to cellular origin in B-cell malignancies.
- The germinal center (GC) is a key microenvironment influencing B-cell development and malignant transformation.
Purpose of the Study:
- To investigate the correlation between telomere length and specific B-cell lymphoma/leukemia subtypes.
- To assess the relationship between telomere length, immunoglobulin (Ig) mutation status, and GC/non-GC classification in diffuse large B-cell lymphoma (DLBCL).
Main Methods:
- Quantitative PCR was used to measure telomere length in 223 B-cell lymphoma/leukemia samples.
- Telomere length data were correlated with Ig mutation status and GC/non-GC immunostaining results.
Main Results:
- Shortest telomeres were observed in Ig-unmutated chronic lymphocytic leukemia (CLL).
- Telomere length significantly differed between GC-like and non-GC-like DLBCL subtypes.
- Follicular lymphomas (FLs) exhibited shorter telomeres compared to GC-DLBCL.
Conclusions:
- Telomere length serves as a distinguishing factor for certain B-cell malignancies like DLBCL and CLL.
- Telomere length reflects multiple biological parameters and may not solely correlate with germinal center-related origin.
Related Concept Videos
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
01:29Replication in Eukaryotes
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
02:31Replication in Eukaryotes
Overview
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...